EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Update on the Role of FeNO in Asthma Management

Neveda Murugesan, Damini Saxena iD, Arundhati Dileep, Muhammad Adrish, Nicola A Hanania

Diagnostics · 15.04.2023 · 13 (8) · 1428

DOI: 10.3390/diagnostics13081428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 15.04.2023. Verfasst von Neveda Murugesan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is a heterogenous disorder characterized by presence of different phenotypes and endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk of morbidity and mortality. Fractional exhaled nitric oxide (FeNO) is a cost-effective, point of care biomarker that is used to detect type 2 airway inflammation. Guidelines have proposed to measure FeNO as an adjunct to diagnostic evaluation in individuals with suspected asthma and to monitor airway inflammation. FeNO has lower sensitivity, suggesting that it may not be a good biomarker to rule out asthma. FeNO may also be used to predict response to inhaled corticosteroids, predict adherence and deciding on biologic therapy. Higher levels of FeNO have been associated with lower lung function and increased risk for future asthma exacerbations and its predictive value increases when combined with other standard measurements of asthma assessment.

Schlagwörter

Stichwörter der Autor:innen

FeNOasthmafractional excretion of nitric oxideoutcomes

Autor:innen und Institutionen

  • Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Division of Pulmonary & Critical Care Medicine, Bronx Care Health System, Bronx, NY 10457, USA.

ORCID-Profile: Damini Saxena

Zitieren

APA

Murugesan, N., Saxena, D., Dileep, A., Adrish, M., & Hanania, N. A. (2023). Update on the Role of FeNO in Asthma Management. Diagnostics, 13(8), 1428. https://doi.org/10.3390/diagnostics13081428

Vancouver

Murugesan N, Saxena D, Dileep A, Adrish M, Hanania NA. Update on the Role of FeNO in Asthma Management. Diagnostics. 2023;13(8):1428. doi:10.3390/diagnostics13081428

BibTeX
@article{Murugesan2023,
  author = {Murugesan, Neveda and Saxena, Damini and Dileep, Arundhati and Adrish, Muhammad and Hanania, Nicola A},
  title = {Update on the Role of FeNO in Asthma Management},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {8},
  pages = {1428},
  doi = {10.3390/diagnostics13081428}
}
Kostenlos starten →